NextFin News - In a move that underscores the administration’s aggressive stance on domestic industrial sovereignty, U.S. President Trump signed an executive order on Wednesday, February 18, 2026, invoking the Defense Production Act (DPA) to prioritize the domestic production of glyphosate and elemental phosphorus. The order, announced from the White House, designates these chemicals as essential to the national defense, effectively placing the weight of the federal government behind the supply chains of the world’s most widely used herbicide.
The executive order delegates authority to the Secretary of Agriculture, Brooke Rollins, to require the performance of contracts and allocate materials necessary to ensure an uninterrupted supply of these products. According to a White House fact sheet, the administration views the current reliance on foreign imports—primarily generic versions from China—as a grave vulnerability to the U.S. defense industrial base and food supply. Elemental phosphorus, a key precursor for glyphosate, is also a critical component in military equipment, further justifying the use of the DPA under the umbrella of national security.
The timing of the order is particularly significant for the corporate landscape. Bayer, the German conglomerate that acquired Monsanto in 2018, remains the sole domestic producer of glyphosate in the United States. On Tuesday, just one day before the executive order, Bayer proposed a $7.25 billion settlement to resolve thousands of U.S. lawsuits alleging that its Roundup herbicide causes non-Hodgkin’s lymphoma. By invoking the DPA, U.S. President Trump has not only secured the supply chain but also provided a regulatory shield for the industry. The order specifically directs Secretary Rollins to ensure that federal regulations do not place the "corporate viability" of domestic producers at risk, a clause widely interpreted as a safeguard against the litigation and environmental restrictions that have plagued Bayer for years.
From an analytical perspective, this executive action represents a fusion of agricultural policy and national defense strategy. By framing glyphosate as a matter of "food security," the administration is utilizing a framework that prioritizes yield efficiency and supply chain resilience over the precautionary principle often cited by health advocates. Glyphosate-based herbicides are the backbone of modern U.S. row-crop agriculture, particularly for corn and soybeans. According to data from the House Committee on Agriculture, glyphosate enables the efficient production of livestock feed and food staples that keep American grocery prices stable. In an era of global trade volatility, the administration is betting that the economic cost of a supply disruption outweighs the potential health risks debated by international bodies.
However, the move has ignited a firestorm within the "Make America Healthy Again" (MAHA) movement, a key constituency for the administration. While U.S. Health Secretary Robert F. Kennedy Jr. issued a statement supporting the President’s focus on national security, many of his supporters view the entrenchment of chemical herbicides as a betrayal of promises to reform the American food system. The International Agency for Research on Cancer (IARC), a branch of the World Health Organization, continues to classify glyphosate as a "probable carcinogen," a stance that stands in direct opposition to the U.S. Environmental Protection Agency’s (EPA) current findings. This internal tension suggests that while the executive order provides immediate industrial stability, it may create long-term political friction between the administration’s industrial and public health agendas.
Looking forward, the invocation of the DPA for agricultural chemicals sets a precedent for how the administration might handle other critical inputs, such as fertilizers and specialized seeds. We can expect an increase in federal subsidies and regulatory streamlining for domestic chemical manufacturing, aimed at decoupling the U.S. agricultural sector from Chinese precursors. For Bayer and the broader agrochemical industry, this order provides a much-needed reprieve from the "litigation trap," potentially stabilizing the company’s stock and encouraging further investment in U.S.-based facilities. Nevertheless, the legal battle is far from over; as the Supreme Court prepares to hear related cases, the tension between federal defense mandates and state-level tort law will likely become the next major frontier for the industry.
Explore more exclusive insights at nextfin.ai.
